Cargando…

Efficacy, safety and tolerability of field treatment of actinic keratosis with ingenol mebutate 0.015 % gel: a single center case series

INTRODUCTION: Actinic keratosis (AK) is a cutaneous intraepithelial neoplasm appearing within areas referred as ‘fields of cancerization’. AK can progress to invasive squamous cell carcinoma. Treatments that target both clinically visible and subclinical AKs in cancerization fields are able to reduc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bobyr, Ivan, Campanati, Anna, Consales, Veronica, Giuliodori, Katia, Scalise, Alessandro, Offidani, Annamaria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2016
Materias:	Case Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4870479/ https://www.ncbi.nlm.nih.gov/pubmed/27330893 http://dx.doi.org/10.1186/s40064-016-2290-6

Ejemplares similares

Assessment of local skin reactions with a sequential regimen of cryosurgery followed by ingenol mebutate gel, 0.015%, in patients with actinic keratosis
por: Goldenberg, Gary, et al.
Publicado: (2014)

Superficial Basal Cell Carcinoma Treated with Two Cycles of Ingenol Mebutate Gel 0.015%
por: Jung, Yu Seok, et al.
Publicado: (2016)

Nodular basal cell carcinoma of the face successfully treated with ingenol mebutate 0.015% gel
por: Iannazzone, Silvia S., et al.
Publicado: (2018)

Treatment of actinic keratoses and cancerization field of the face and scalp with 0.015% ingenol mebutate gel in Brazilian individuals: safety, tolerability and patients' perspectives
por: Gameiro, Luiz, et al.
Publicado: (2019)

Improved patient satisfaction using ingenol mebutate gel 0.015% for the treatment of facial actinic keratoses: a prospective pilot study
por: Emilio, Joanna, et al.
Publicado: (2016)

New developments in the treatment of actinic keratosis: focus on ingenol mebutate gel
por: Berman, Brian
Publicado: (2012)

Efficacy of ingenol mebutate gel for actinic keratosis in patients treated by thiazide diuretics
por: Campione, Elena, et al.
Publicado: (2016)

Ingenol mebutate: A novel topical drug for actinic keratosis
por: Aditya, Suruchi, et al.
Publicado: (2013)

Identification of differentially expressed genes in actinic keratosis samples treated with ingenol mebutate gel
por: Segura, Sonia, et al.
Publicado: (2020)

Willingness-to-pay to access Ingenol Mebutate Gel for Actinic Keratosis Treatment in the U.S. Setting
por: Willis, Michael, et al.
Publicado: (2014)

Ingenol mebutate in low amounts for the treatment of actinic keratosis in Korean patients
por: Joe, Hyun Jae, et al.
Publicado: (2017)

Factors influencing response to ingenol mebutate therapy for actinic keratosis of face and scalp
por: Skroza, Nevena, et al.
Publicado: (2017)

Ingenol mebutate treatment in actinic keratosis – clinical effectiveness and potential side effects
por: Lesiak, Aleksandra, et al.
Publicado: (2019)

Dermoscopy and Reflectance Confocal Microscopy for Monitoring the Treatment of Actinic Keratosis with Ingenol Mebutate Gel: Report of Two Cases
por: Longo, Caterina, et al.
Publicado: (2016)

Clinical utility of ingenol mebutate in the management of actinic keratosis: perspectives from clinical practice
por: Skroza, Nevena, et al.
Publicado: (2018)

The Role of Ingenol Mebutate in the Treatment of Actinic Keratoses
por: Ali, Faisal R., et al.
Publicado: (2012)

Cost-efficacy analysis of 3% diclofenac sodium, ingenol mebutate, and 3.75% imiquimod in the treatment of actinic keratosis
por: Nisticò, Steven, et al.
Publicado: (2018)

Ingenol mebutate treatment in keloids
por: De Felice, Bruna, et al.
Publicado: (2015)

Tattoo removal with ingenol mebutate
por: Cozzi, Sarah-Jane, et al.
Publicado: (2017)

Treatment of superficial basal cell carcinoma with ingenol mebutate gel, 0.05%
por: Bettencourt, Miriam S
Publicado: (2016)

Pronounced local skin reaction to ingenol mebutate against actinic keratosis in kidney transplant recipient without systemic adverse events
por: Mohanna, Mosab, et al.
Publicado: (2015)

A New, Objective, Quantitative Scale for Measuring Local Skin Responses Following Topical Actinic Keratosis Therapy with Ingenol Mebutate
por: Rosen, Robert, et al.
Publicado: (2014)

Ingenol mebutate in the treatment of actinic keratoses: clearance rate and adverse effects
por: Saraiva, Maria Isabel Ramos, et al.
Publicado: (2018)

Role of mesenchymal stem cells in the pathogenesis of psoriasis: current perspectives
por: Campanati, Anna, et al.
Publicado: (2017)

A Case of Bowen's Disease Successfully Treated with Ingenol Mebutate Gel
por: Chae, Je-Byeong, et al.
Publicado: (2017)

Field cancerization therapy with ingenol mebutate contributes to restoring skin-metabolism to normal-state in patients with actinic keratosis: a metabolomic analysis
por: Righi, Valeria, et al.
Publicado: (2019)

A randomized trial comparing simultaneous vs. sequential field treatment of actinic keratosis with ingenol mebutate on two separate areas of the head and body
por: Pellacani, G., et al.
Publicado: (2015)

DRAFT ATLAS ATRECON manual (Version 0.015)
por: Offline Software Group
Publicado: (1994)

Recurrent In Situ Melanoma Successfully Treated with Ingenol Mebutate
por: Mansuy, Marion, et al.
Publicado: (2014)

Tumor-Preferential Induction of Immune Responses and Epidermal Cell Death in Actinic Keratoses by Ingenol Mebutate
por: Emmert, Steffen, et al.
Publicado: (2016)

Efficacy of Ingenol Mebutate in the Treatment of Actinic Keratoses: A Pre- and Posttreatment Dermoscopic Comparative Analysis
por: Carbotti, Mattia, et al.
Publicado: (2018)

IL-1 Contributes to the Anti-Cancer Efficacy of Ingenol Mebutate
por: Le, Thuy T., et al.
Publicado: (2016)

Ingenol Mebutate: A Succinct Review of a Succinct Therapy
por: Alchin, David Rhys
Publicado: (2014)

Multipuncture technique with ingenol mebutate in the treatment of a periungual wart
por: Dellatorre, Gerson, et al.
Publicado: (2018)

Effective treatment of squamous cell carcinomas with ingenol mebutate gel in immunologically intact SKH1 mice
por: Cozzi, Sarah-Jane, et al.
Publicado: (2012)

Topical ingenol mebutate is effective against plantar warts in immunocompromised patients
por: Mrad, Marc, et al.
Publicado: (2017)

Immunothrombotic Mechanisms Induced by Ingenol Mebutate Lead to Rapid Necrosis and Clearance of Anogenital Warts
por: Braun, Stephan A., et al.
Publicado: (2022)

Ingenol Disoxate: A Novel 4-Isoxazolecarboxylate Ester of Ingenol with Improved Properties for Treatment of Actinic Keratosis and Other Non-Melanoma Skin Cancers
por: Bertelsen, Malene, et al.
Publicado: (2016)

Efficacy and safety of 0.05% ingenol mebutate in the treatment of basal cell carcinoma: A prospective study
por: Velin, Marine, et al.
Publicado: (2022)

Relationship between severity of the local skin reactions and the rate of local skin reaction resolution in patients treated with ingenol mebutate gel
por: Jim On, Shelbi C, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_hhg12c3dnmigskhnb4kh4k7rf5